Are all true about staing of Beta blocker therapy in patients with congestive hea failure except
High-Yield Explanation
Clinical use of Beta adrenergic receptors antagonists in hea failure These are now recommended for routine use in patient with an ejection fraction <35% and NYHA class 2 and 3 symptoms in conjunction with ACE inhibitors or Angiotensin antagonist receptors and diuretics This should be initiated at very low doses, generally less than one tenth of the final target dose Goodman and Gilman 11e p1336